Develops antibodies for cancer and eye diseases.
Dec 2024Revenue $183K/yrExpenses $10.1M/yr
No trend
Figures by year
When will Abpro Holdings be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2024, revenue was $183K and expenses $10.1M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2024 | $183K | $10.1M | −$9.92M |
| Dec 2023 | $122K | $11.9M | −$11.7M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.